Prevention of cardiac hypertrophy with omega 3-fatty acids

Potential cell signaling targets

Rafat A. Siddiqui, Carlos A. Labarrere, Richard Kovacs

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Epidemiological studies of Greenland Eskimos and Japanese have suggested that eating fish oil and marine animals can prevent heart disease. The beneficial effects of fish oils are attributed to their omega 3-fatty acid (O3FA) content, particularly, eicosapentaenoic acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA, 22:6n-3). DHA and EPA in the diet influence the fatty acid composition of plasma membrane phospholipids in cardiac tissues, which may affect cardiac cell functions. However, very little is known about the cellular and molecular mechanisms that mediate O3FA-induced cardio-protective effects. This review describes the potential cellular targets that can be modulated by O3FAs to regulate cardiac-related illnesses, particularly, cardiomyocyte hypertrophy. Among various biochemical derangements, the increase in intracellular Ca2+ ([Ca2+]i) allows the development of cardiac hypertrophy. Elevation of [Ca2+]i acts as a central intracellular signaling system by which hormones and growth factors regulate many different processes, such as secretion, metabolism, cell growth, differentiation, and cell contractility. Recent studies clearly suggest that O3FAs have profound effects on reducing [Ca2+]i levels by regulating both influx of Ca2+ through Ca2+ channels and mobilization of Ca2+ from intracellular stores. These fatty acids modulate Ca2+ current through the L-type calcium channels, and the effects occur within minutes of adding EPA or DHA to the medium. O3FAs can also regulate calcium mobilization from intracellular stores by affecting phosphatidylinositol cycle, phospholipase C activities, and inositol 1, 4, 5 trisphosphate generation. The effect of O3FAs on reducing the [Ca2+]i levels could be one of the mechanisms for preventing cardiac hypertrophy. In addition to affecting [Ca2+]i levels, these fatty acids can also affect other signaling pathways, including alterations in receptor affinity and density, activities of adenylate and guanylate cyclase, and cyclic nucleotide phosphodiesterase activities. There is no direct evidence that O3FAs affect src, ras, and MAP kinase signal transduction pathways in cardiac tissues, but in other cellular systems these pathways can be modulated by O3FAs. It therefore appears that a blockade of src, ras, and MAP kinase pathways, which is known to be involved in the development of cardiac hypertrophy, could be an effective target for O3FAs. Another important process in the development of cardiac hypertrophy is the activation of protein kinase C (PKC) isoenzymes. PKC activation leads to stimulation of specific pathways that mediate protein synthesis in cardiomyocytes. There is clear evidence that O3FAs affect the translocation and activation of PKC in cardiac tissues through multiple mechanisms. The modulation of PKC activities therefore could prevent the development of hormonal-induced cardiac hypertrophy by acting on multiple cellular signaling pathways.

Original languageEnglish
Pages (from-to)1145-1156
Number of pages12
JournalCurrent Organic Chemistry
Volume4
Issue number11
StatePublished - 2000

Fingerprint

Cell signaling
Omega-3 Fatty Acids
Protein Kinase C
Fatty Acids
Fish Oils
Chemical activation
Tissue
Phosphotransferases
L-Type Calcium Channels
Signal transduction
Inositol 1,4,5-Trisphosphate
Eicosapentaenoic Acid
Docosahexaenoic Acids
Guanylate Cyclase
Cyclic Nucleotides
Hormones
Phosphoric Diester Hydrolases
Cell growth
Type C Phospholipases
Cell membranes

ASJC Scopus subject areas

  • Organic Chemistry

Cite this

Prevention of cardiac hypertrophy with omega 3-fatty acids : Potential cell signaling targets. / Siddiqui, Rafat A.; Labarrere, Carlos A.; Kovacs, Richard.

In: Current Organic Chemistry, Vol. 4, No. 11, 2000, p. 1145-1156.

Research output: Contribution to journalArticle

@article{3f6b5982fc7e4c4c80864c0f6e4bb3d1,
title = "Prevention of cardiac hypertrophy with omega 3-fatty acids: Potential cell signaling targets",
abstract = "Epidemiological studies of Greenland Eskimos and Japanese have suggested that eating fish oil and marine animals can prevent heart disease. The beneficial effects of fish oils are attributed to their omega 3-fatty acid (O3FA) content, particularly, eicosapentaenoic acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA, 22:6n-3). DHA and EPA in the diet influence the fatty acid composition of plasma membrane phospholipids in cardiac tissues, which may affect cardiac cell functions. However, very little is known about the cellular and molecular mechanisms that mediate O3FA-induced cardio-protective effects. This review describes the potential cellular targets that can be modulated by O3FAs to regulate cardiac-related illnesses, particularly, cardiomyocyte hypertrophy. Among various biochemical derangements, the increase in intracellular Ca2+ ([Ca2+]i) allows the development of cardiac hypertrophy. Elevation of [Ca2+]i acts as a central intracellular signaling system by which hormones and growth factors regulate many different processes, such as secretion, metabolism, cell growth, differentiation, and cell contractility. Recent studies clearly suggest that O3FAs have profound effects on reducing [Ca2+]i levels by regulating both influx of Ca2+ through Ca2+ channels and mobilization of Ca2+ from intracellular stores. These fatty acids modulate Ca2+ current through the L-type calcium channels, and the effects occur within minutes of adding EPA or DHA to the medium. O3FAs can also regulate calcium mobilization from intracellular stores by affecting phosphatidylinositol cycle, phospholipase C activities, and inositol 1, 4, 5 trisphosphate generation. The effect of O3FAs on reducing the [Ca2+]i levels could be one of the mechanisms for preventing cardiac hypertrophy. In addition to affecting [Ca2+]i levels, these fatty acids can also affect other signaling pathways, including alterations in receptor affinity and density, activities of adenylate and guanylate cyclase, and cyclic nucleotide phosphodiesterase activities. There is no direct evidence that O3FAs affect src, ras, and MAP kinase signal transduction pathways in cardiac tissues, but in other cellular systems these pathways can be modulated by O3FAs. It therefore appears that a blockade of src, ras, and MAP kinase pathways, which is known to be involved in the development of cardiac hypertrophy, could be an effective target for O3FAs. Another important process in the development of cardiac hypertrophy is the activation of protein kinase C (PKC) isoenzymes. PKC activation leads to stimulation of specific pathways that mediate protein synthesis in cardiomyocytes. There is clear evidence that O3FAs affect the translocation and activation of PKC in cardiac tissues through multiple mechanisms. The modulation of PKC activities therefore could prevent the development of hormonal-induced cardiac hypertrophy by acting on multiple cellular signaling pathways.",
author = "Siddiqui, {Rafat A.} and Labarrere, {Carlos A.} and Richard Kovacs",
year = "2000",
language = "English",
volume = "4",
pages = "1145--1156",
journal = "Current Organic Chemistry",
issn = "1385-2728",
publisher = "Bentham Science Publishers B.V.",
number = "11",

}

TY - JOUR

T1 - Prevention of cardiac hypertrophy with omega 3-fatty acids

T2 - Potential cell signaling targets

AU - Siddiqui, Rafat A.

AU - Labarrere, Carlos A.

AU - Kovacs, Richard

PY - 2000

Y1 - 2000

N2 - Epidemiological studies of Greenland Eskimos and Japanese have suggested that eating fish oil and marine animals can prevent heart disease. The beneficial effects of fish oils are attributed to their omega 3-fatty acid (O3FA) content, particularly, eicosapentaenoic acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA, 22:6n-3). DHA and EPA in the diet influence the fatty acid composition of plasma membrane phospholipids in cardiac tissues, which may affect cardiac cell functions. However, very little is known about the cellular and molecular mechanisms that mediate O3FA-induced cardio-protective effects. This review describes the potential cellular targets that can be modulated by O3FAs to regulate cardiac-related illnesses, particularly, cardiomyocyte hypertrophy. Among various biochemical derangements, the increase in intracellular Ca2+ ([Ca2+]i) allows the development of cardiac hypertrophy. Elevation of [Ca2+]i acts as a central intracellular signaling system by which hormones and growth factors regulate many different processes, such as secretion, metabolism, cell growth, differentiation, and cell contractility. Recent studies clearly suggest that O3FAs have profound effects on reducing [Ca2+]i levels by regulating both influx of Ca2+ through Ca2+ channels and mobilization of Ca2+ from intracellular stores. These fatty acids modulate Ca2+ current through the L-type calcium channels, and the effects occur within minutes of adding EPA or DHA to the medium. O3FAs can also regulate calcium mobilization from intracellular stores by affecting phosphatidylinositol cycle, phospholipase C activities, and inositol 1, 4, 5 trisphosphate generation. The effect of O3FAs on reducing the [Ca2+]i levels could be one of the mechanisms for preventing cardiac hypertrophy. In addition to affecting [Ca2+]i levels, these fatty acids can also affect other signaling pathways, including alterations in receptor affinity and density, activities of adenylate and guanylate cyclase, and cyclic nucleotide phosphodiesterase activities. There is no direct evidence that O3FAs affect src, ras, and MAP kinase signal transduction pathways in cardiac tissues, but in other cellular systems these pathways can be modulated by O3FAs. It therefore appears that a blockade of src, ras, and MAP kinase pathways, which is known to be involved in the development of cardiac hypertrophy, could be an effective target for O3FAs. Another important process in the development of cardiac hypertrophy is the activation of protein kinase C (PKC) isoenzymes. PKC activation leads to stimulation of specific pathways that mediate protein synthesis in cardiomyocytes. There is clear evidence that O3FAs affect the translocation and activation of PKC in cardiac tissues through multiple mechanisms. The modulation of PKC activities therefore could prevent the development of hormonal-induced cardiac hypertrophy by acting on multiple cellular signaling pathways.

AB - Epidemiological studies of Greenland Eskimos and Japanese have suggested that eating fish oil and marine animals can prevent heart disease. The beneficial effects of fish oils are attributed to their omega 3-fatty acid (O3FA) content, particularly, eicosapentaenoic acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA, 22:6n-3). DHA and EPA in the diet influence the fatty acid composition of plasma membrane phospholipids in cardiac tissues, which may affect cardiac cell functions. However, very little is known about the cellular and molecular mechanisms that mediate O3FA-induced cardio-protective effects. This review describes the potential cellular targets that can be modulated by O3FAs to regulate cardiac-related illnesses, particularly, cardiomyocyte hypertrophy. Among various biochemical derangements, the increase in intracellular Ca2+ ([Ca2+]i) allows the development of cardiac hypertrophy. Elevation of [Ca2+]i acts as a central intracellular signaling system by which hormones and growth factors regulate many different processes, such as secretion, metabolism, cell growth, differentiation, and cell contractility. Recent studies clearly suggest that O3FAs have profound effects on reducing [Ca2+]i levels by regulating both influx of Ca2+ through Ca2+ channels and mobilization of Ca2+ from intracellular stores. These fatty acids modulate Ca2+ current through the L-type calcium channels, and the effects occur within minutes of adding EPA or DHA to the medium. O3FAs can also regulate calcium mobilization from intracellular stores by affecting phosphatidylinositol cycle, phospholipase C activities, and inositol 1, 4, 5 trisphosphate generation. The effect of O3FAs on reducing the [Ca2+]i levels could be one of the mechanisms for preventing cardiac hypertrophy. In addition to affecting [Ca2+]i levels, these fatty acids can also affect other signaling pathways, including alterations in receptor affinity and density, activities of adenylate and guanylate cyclase, and cyclic nucleotide phosphodiesterase activities. There is no direct evidence that O3FAs affect src, ras, and MAP kinase signal transduction pathways in cardiac tissues, but in other cellular systems these pathways can be modulated by O3FAs. It therefore appears that a blockade of src, ras, and MAP kinase pathways, which is known to be involved in the development of cardiac hypertrophy, could be an effective target for O3FAs. Another important process in the development of cardiac hypertrophy is the activation of protein kinase C (PKC) isoenzymes. PKC activation leads to stimulation of specific pathways that mediate protein synthesis in cardiomyocytes. There is clear evidence that O3FAs affect the translocation and activation of PKC in cardiac tissues through multiple mechanisms. The modulation of PKC activities therefore could prevent the development of hormonal-induced cardiac hypertrophy by acting on multiple cellular signaling pathways.

UR - http://www.scopus.com/inward/record.url?scp=0033677759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033677759&partnerID=8YFLogxK

M3 - Article

VL - 4

SP - 1145

EP - 1156

JO - Current Organic Chemistry

JF - Current Organic Chemistry

SN - 1385-2728

IS - 11

ER -